Covered recipient · General Payments record
ROSANNE L OSOSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$24,611.87
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,378.75 | 1 |
| Travel and Lodging | $1,416.05 | 4 |
| Food and Beverage | $460.75 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $5,078.74 | 6 |
| GENZYME CORPORATION | $114.58 | 1 |
| Octapharma USA, Inc. | $62.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $114.58 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139727192 | CMS |
| Novo Nordisk Inc | $465.88 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1100232286 | CMS |
| Novo Nordisk Inc | $3,378.75 | 10/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1100280064 | CMS |
| Novo Nordisk Inc | $466.34 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1100447397 | CMS |
| Novo Nordisk Inc | $423.53 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1100473806 | CMS |
| Novo Nordisk Inc | $60.30 | 10/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1100492057 | CMS |
| Novo Nordisk Inc | $283.94 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100492059 | CMS |
| Octapharma USA, Inc. | $62.23 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142323094 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.